{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T17:44:51Z","timestamp":1793727891629,"version":"4.6.1"},"reference-count":123,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,7,9]],"date-time":"2025-07-09T00:00:00Z","timestamp":1752019200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,9]],"date-time":"2025-07-09T00:00:00Z","timestamp":1752019200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Heart Fail Rev"],"DOI":"10.1007\/s10741-025-10543-w","type":"journal-article","created":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T09:28:59Z","timestamp":1752139739000},"page":"1225-1238","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Gut microbiota\u2019s role in heart failure"],"prefix":"10.1007","volume":"30","author":[{"given":"Kamila","family":"Florek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Komorowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakub","family":"Ptak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micha\u0142","family":"Jarocki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Gontarczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roksana","family":"Mania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Boluk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa","family":"\u017burawska-P\u0142aksej","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0141ukasz","family":"\u0141aczma\u0144ski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mateusz","family":"Sokolski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,9]]},"reference":[{"key":"10543_CR1","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1002\/ejhf.1858","volume":"22","author":"A Groenewegen","year":"2020","unstructured":"Groenewegen A, Rutten FH, Mosterd A, Hoes AW (2020) Epidemiology of heart failure. Eur J Heart Fail 22:1342\u20131356. https:\/\/doi.org\/10.1002\/ejhf.1858","journal-title":"Eur J Heart Fail"},{"key":"10543_CR2","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1002\/ehf2.14687","volume":"11","author":"O Chioncel","year":"2024","unstructured":"Chioncel O, \u010celutkien\u0117 J, B\u011blohl\u00e1vek J, Kamzola G, Lainscak M, Merkely B, Mili\u010di\u0107 D, Nessler J, Risti\u0107 AD, Sawie\u0142ajc L, Uchmanowicz I, Uuetoa T, Turgonyi E, Yotov Y, Ponikowski P (2024) Heart failure care in the Central and Eastern Europe and Baltic region: status, barriers, and routes to improvement. ESC Heart Failure 11:1861\u20131874. https:\/\/doi.org\/10.1002\/ehf2.14687","journal-title":"ESC Heart Failure"},{"key":"10543_CR3","doi-asserted-by":"publisher","DOI":"10.1002\/ehf2.15095","author":"G Colombo","year":"2024","unstructured":"Colombo G, Biering-Sorensen T, Ferreira JP, Lombardi CM, Bonelli A, Garascia A, Metra M, Inciardi RM (2024) Cardiac remodelling in the era of the recommended four pillars heart failure medical therapy. ESC Heart Failure. https:\/\/doi.org\/10.1002\/ehf2.15095","journal-title":"ESC Heart Failure"},{"key":"10543_CR4","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1002\/ejhf.483","volume":"18","author":"EES Van Riet","year":"2016","unstructured":"Van Riet EES, Hoes AW, Wagenaar KP, Limburg A, Landman MAJ, Rutten FH (2016) Epidemiology of heart failure: the prevalence of heart failure and ventricular dysfunction in older adults over time. A systematic review. Eur J Heart Fail 18:242\u2013252. https:\/\/doi.org\/10.1002\/ejhf.483","journal-title":"Eur J Heart Fail"},{"key":"10543_CR5","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1002\/ejhf.2561","volume":"24","author":"M Pagnesi","year":"2022","unstructured":"Pagnesi M, Lombardi CM, Chiarito M, Stolfo D, Baldetti L, Loiacono F, Tedino C, Arrigoni L, Ghiraldin D, Tomasoni D, Inciardi RM, Maccallini M, Villaschi A, Gasparini G, Montella M, Contessi S, Cocianni D, Perotto M, Barone G, Merlo M, Cappelletti AM, Sinagra G, Pini D, Metra M (2022) Prognostic impact of the updated 2018 HFA-ESC definition of advanced heart failure: results from the HELP-HF registry. Eur J Heart Fail 24:1493\u20131503. https:\/\/doi.org\/10.1002\/ejhf.2561","journal-title":"Eur J Heart Fail"},{"key":"10543_CR6","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1002\/ehf2.14539","volume":"11","author":"M Pagnesi","year":"2023","unstructured":"Pagnesi M, Lombardi CM, Tedino C, Chiarito M, Stolfo D, Baldetti L, Adamo M, Cal\u00ec F, Inciardi RM, Tomasoni D, Loiacono F, Maccallini M, Villaschi A, Gasparini G, Montella M, Contessi S, Cocianni D, Perotto M, Barone G, Merlo M, Cappelletti AM, Sinagra G, Pini D, Metra M (2023) Role of ejection fraction in patients at risk for advanced heart failure: insights from the HELP-HF registry. ESC Heart Failure 11:136\u2013146. https:\/\/doi.org\/10.1002\/ehf2.14539","journal-title":"ESC Heart Failure"},{"key":"10543_CR7","doi-asserted-by":"publisher","DOI":"10.1002\/ehf2.15114","author":"B Guo","year":"2024","unstructured":"Guo B, Shi S, Guo Y, Xiong J, Wang B, Dong Z, Gao D, Tu Y (2024) Interventional therapies for chronic heart failure: an overview of recent developments. ESC Heart Failure. https:\/\/doi.org\/10.1002\/ehf2.15114","journal-title":"ESC Heart Failure"},{"key":"10543_CR8","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/S0167-5273(99)00186-2","volume":"72","author":"R Sharma","year":"2000","unstructured":"Sharma R, Coats AJS, Anker SD (2000) The role of inflammatory mediators in chronic heart failure: cytokines, nitric oxide, and endothelin-1. Int J Cardiol 72:175\u2013186. https:\/\/doi.org\/10.1016\/S0167-5273(99)00186-2","journal-title":"Int J Cardiol"},{"key":"10543_CR9","first-page":"158","volume":"12","author":"O Amir","year":"2010","unstructured":"Amir O, Rogowski O, David M, Lahat N, Wolff R, Lewis BS (2010) Circulating interleukin-10: association with higher mortality in systolic heart failure patients with elevated tumor necrosis factor-alpha. Isr Med Assoc J IMAJ 12:158\u2013162","journal-title":"Isr Med Assoc J IMAJ"},{"key":"10543_CR10","doi-asserted-by":"publisher","first-page":"3530","DOI":"10.1002\/ehf2.14968","volume":"11","author":"L Baumhove","year":"2024","unstructured":"Baumhove L, Van Essen BJ, Dokter MM, Zijlstra SN, Deiman FE, Laman JD, Lang CC, Verstappen GMPJ, Van Veldhuisen DJ, Van Der Meer P, Bomer N, Voors AA (2024) IL-17 is associated with disease severity and targetable inflammatory processes in heart failure. ESC Heart Failure 11:3530\u20133538. https:\/\/doi.org\/10.1002\/ehf2.14968","journal-title":"ESC Heart Failure"},{"key":"10543_CR11","doi-asserted-by":"publisher","DOI":"10.1002\/ehf2.15164","author":"J Biegus","year":"2024","unstructured":"Biegus J, Gajewski P, Ponikowski P (2024) Congestion, decongestion, renal function and diuretics in (ESC) heart failure. ESC Heart Failure. https:\/\/doi.org\/10.1002\/ehf2.15164","journal-title":"ESC Heart Failure"},{"key":"10543_CR12","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1016\/S0002-9149(97)00159-8","volume":"79","author":"SD Anker","year":"1997","unstructured":"Anker SD, Egerer KR, Volk H-D, Kox WJ, Poole-Wilson PA, Coats AJS (1997) Elevated soluble CD14 receptors and altered cytokines in chronic heart failure. Am J Cardiol 79:1426\u20131430. https:\/\/doi.org\/10.1016\/S0002-9149(97)00159-8","journal-title":"Am J Cardiol"},{"key":"10543_CR13","doi-asserted-by":"publisher","first-page":"2368","DOI":"10.1093\/eurheartj\/ehi389","volume":"26","author":"A Krack","year":"2005","unstructured":"Krack A, Sharma R, Figulla HR, Anker SD (2005) The importance of the gastrointestinal system in the pathogenesis of heart failure. Eur Heart J 26:2368\u20132374. https:\/\/doi.org\/10.1093\/eurheartj\/ehi389","journal-title":"Eur Heart J"},{"key":"10543_CR14","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1016\/j.jacc.2007.07.016","volume":"50","author":"A Sandek","year":"2007","unstructured":"Sandek A, Bauditz J, Swidsinski A, Buhner S, Weber-Eibel J, Von Haehling S, Schroedl W, Karhausen T, Doehner W, Rauchhaus M, Poole-Wilson P, Volk H-D, Lochs H, Anker SD (2007) Altered intestinal function in patients with chronic heart failure. J Am Coll Cardiol 50:1561\u20131569. https:\/\/doi.org\/10.1016\/j.jacc.2007.07.016","journal-title":"J Am Coll Cardiol"},{"key":"10543_CR15","doi-asserted-by":"publisher","DOI":"10.1002\/ehf2.14991","author":"J Roessler","year":"2024","unstructured":"Roessler J, Zimmermann F, Heidecker B, Landmesser U, Haghikia A (2024) Gut microbiota-related modulation of immune mechanisms in post-infarction remodelling and heart failure. ESC Heart Failure. https:\/\/doi.org\/10.1002\/ehf2.14991","journal-title":"ESC Heart Failure"},{"key":"10543_CR16","doi-asserted-by":"publisher","DOI":"10.1002\/ehf2.14947","author":"Z Fang","year":"2024","unstructured":"Fang Z, Raza U, Song J, Lu J, Yao S, Liu X, Zhang W, Li S (2024) Systemic aging fuels heart failure: molecular mechanisms and therapeutic avenues. ESC Heart Failure. https:\/\/doi.org\/10.1002\/ehf2.14947","journal-title":"ESC Heart Failure"},{"key":"10543_CR17","doi-asserted-by":"publisher","first-page":"4366","DOI":"10.1002\/ehf2.14139","volume":"9","author":"JJ Wong","year":"2022","unstructured":"Wong JJ, Purbojati RW, Tan R, Pettersson S, Koh AS (2022) Distinct gut microbiota composition among older adults with myocardial ageing. ESC Heart Failure 9:4366\u20134368. https:\/\/doi.org\/10.1002\/ehf2.14139","journal-title":"ESC Heart Failure"},{"key":"10543_CR18","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1002\/ehf2.13290","volume":"8","author":"Y Kinugasa","year":"2021","unstructured":"Kinugasa Y, Nakamura K, Kamitani H, Hirai M, Yanagihara K, Kato M, Yamamoto K (2021) Trimethylamine N-oxide and outcomes in patients hospitalized with acute heart failure and preserved ejection fraction. ESC Heart Fail 8:2103\u20132110. https:\/\/doi.org\/10.1002\/ehf2.13290","journal-title":"ESC Heart Fail"},{"key":"10543_CR19","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1016\/j.jacc.2014.02.617","volume":"64","author":"WHW Tang","year":"2014","unstructured":"Tang WHW, Wang Z, Fan Y, Levison B, Hazen JE, Donahue LM, Wu Y, Hazen SL (2014) Prognostic value of elevated levels of intestinal microbe-generated metabolite trimethylamine-N-oxide in patients with heart failure. J Am Coll Cardiol 64:1908\u20131914. https:\/\/doi.org\/10.1016\/j.jacc.2014.02.617","journal-title":"J Am Coll Cardiol"},{"key":"10543_CR20","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1136\/heartjnl-2015-308826","volume":"102","author":"T Suzuki","year":"2016","unstructured":"Suzuki T, Heaney LM, Bhandari SS, Jones DJL, Ng LL (2016) Trimethylamine N-oxide and prognosis in acute heart failure. Heart 102:841\u2013848. https:\/\/doi.org\/10.1136\/heartjnl-2015-308826","journal-title":"Heart"},{"key":"10543_CR21","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/s41392-022-00974-4","volume":"7","author":"K Hou","year":"2022","unstructured":"Hou K, Wu Z-X, Chen X-Y, Wang J-Q, Zhang D, Xiao C, Zhu D, Koya JB, Wei L, Li J, Chen Z-S (2022) Microbiota in health and diseases. Signal Transduct Target Ther 7:135. https:\/\/doi.org\/10.1038\/s41392-022-00974-4","journal-title":"Signal Transduct Target Ther"},{"key":"10543_CR22","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/nature08821","volume":"464","author":"J Qin","year":"2010","unstructured":"MetaHIT Consortium, Qin J, Li R, Raes J, Arumugam M, Burgdorf KS, Manichanh C, Nielsen T, Pons N, Levenez F, Yamada T, Mende DR, Li J, Xu J, Li S, Li D, Cao J, Wang B, Liang H, Zheng H, Xie Y, Tap J, Lepage P, Bertalan M, Batto J-M, Hansen T, Le Paslier D, Linneberg A, Nielsen HB, Pelletier E, Renault P, Sicheritz-Ponten T, Turner K, Zhu H, Yu C, Li S, Jian M, Zhou Y, Li Y, Zhang X, Li S, Qin N, Yang H, Wang J, Brunak S, Dor\u00e9 J, Guarner F, Kristiansen K, Pedersen O, Parkhill J, Weissenbach J, Bork P, Ehrlich SD, Wang J (2010) A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464:59\u201365. https:\/\/doi.org\/10.1038\/nature08821","journal-title":"Nature"},{"key":"10543_CR23","doi-asserted-by":"publisher","first-page":"e6074","DOI":"10.1371\/journal.pone.0006074","volume":"4","author":"X Yang","year":"2009","unstructured":"Yang X, Xie L, Li Y, Wei C (2009) More than 9,000,000 unique genes in human gut bacterial community: estimating gene numbers inside a human body. PLoS ONE 4:e6074. https:\/\/doi.org\/10.1371\/journal.pone.0006074","journal-title":"PLoS ONE"},{"key":"10543_CR24","doi-asserted-by":"crossref","unstructured":"Regunathan-Shenk R, Shah NB, Raj DS (2022) The gut microbiome and the kidney. In: Nutritional Management of Renal Disease. Elsevier, pp 147\u2013161","DOI":"10.1016\/B978-0-12-818540-7.00031-8"},{"key":"10543_CR25","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.1038\/s41591-022-02014-8","volume":"28","author":"L Chen","year":"2022","unstructured":"Chen L, Zhernakova DV, Kurilshikov A, Andreu-S\u00e1nchez S, Wang D, Augustijn HE, Vila AV, Weersma RK, Medema MH, Netea MG, Kuipers F, Wijmenga C, Zhernakova A, Fu J (2022) Influence of the microbiome, diet and genetics on inter-individual variation in the human plasma metabolome. Nat Med 28:2333\u20132343. https:\/\/doi.org\/10.1038\/s41591-022-02014-8","journal-title":"Nat Med"},{"key":"10543_CR26","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1038\/s41591-018-0160-1","volume":"24","author":"M Deschasaux","year":"2018","unstructured":"Deschasaux M, Bouter KE, Prodan A, Levin E, Groen AK, Herrema H, Tremaroli V, Bakker GJ, Attaye I, Pinto-Sietsma S-J, Van Raalte DH, Snijder MB, Nicolaou M, Peters R, Zwinderman AH, B\u00e4ckhed F, Nieuwdorp M (2018) Depicting the composition of gut microbiota in a population with varied ethnic origins but shared geography. Nat Med 24:1526\u20131531. https:\/\/doi.org\/10.1038\/s41591-018-0160-1","journal-title":"Nat Med"},{"key":"10543_CR27","doi-asserted-by":"publisher","unstructured":"Zhang S-Y (2025) Chinese guidelines for the diagnosis and treatment of heart failure 2024. Journal of Geriatric Cardiology 22:277\u2013331. https:\/\/doi.org\/10.26599\/1671-5411.2025.03.002","DOI":"10.26599\/1671-5411.2025.03.002"},{"key":"10543_CR28","doi-asserted-by":"publisher","unstructured":"Bradley E, Haran J (2024) The human gut microbiome and aging. Gut Microbes 16. https:\/\/doi.org\/10.1080\/19490976.2024.2359677","DOI":"10.1080\/19490976.2024.2359677"},{"key":"10543_CR29","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1136\/gutjnl-2019-320438","volume":"69","author":"V Meslier","year":"2020","unstructured":"Meslier V, Laiola M, Roager HM, De Filippis F, Roume H, Quinquis B, Giacco R, Mennella I, Ferracane R, Pons N, Pasolli E, Rivellese A, Dragsted LO, Vitaglione P, Ehrlich SD, Ercolini D (2020) Mediterranean diet intervention in overweight and obese subjects lowers plasma cholesterol and causes changes in the gut microbiome and metabolome independently of energy intake. Gut 69:1258\u20131268. https:\/\/doi.org\/10.1136\/gutjnl-2019-320438","journal-title":"Gut"},{"key":"10543_CR30","doi-asserted-by":"publisher","unstructured":"Ira R, Adwani J, Krishnan AO, Subramanian G, Yadav S, Shukla S, Rao S, Prakash T (2024) Understanding aging through the lense of gut microbiome. Exploratory Research and Hypothesis in Medicine 9:294. https:\/\/doi.org\/10.14218\/erhm.2024.00008","DOI":"10.14218\/erhm.2024.00008"},{"key":"10543_CR31","doi-asserted-by":"publisher","unstructured":"Vila AV, Collij V, Sanna S, Sinha T, Imhann F, Bourgonje AR, Mujagic Z, Jonkers DM a. E, Masclee A a. M, Fu J, Kurilshikov A, Wijmenga C, Zhernakova A, Weersma RK (2020) Impact of commonly used drugs on the composition and metabolic function of the gut microbiota. Nature Communications 11. https:\/\/doi.org\/10.1038\/s41467-019-14177-z","DOI":"10.1038\/s41467-019-14177-z"},{"key":"10543_CR32","doi-asserted-by":"publisher","first-page":"952","DOI":"10.3390\/biomedicines11030952","volume":"11","author":"H Mruk-Mazurkiewicz","year":"2023","unstructured":"Mruk-Mazurkiewicz H, Kulaszy\u0144ska M, Jakubczyk K, Janda-Milczarek K, Czarnecka W, R\u0119bacz-Maron E, Zacha S, Sie\u0144ko J, Zeair S, Dalewski B, Marlicz W, \u0141oniewski I, Skonieczna-\u017bydecka K (2023) Clinical relevance of gut microbiota alterations under the influence of selected drugs\u2014updated review. Biomedicines 11:952. https:\/\/doi.org\/10.3390\/biomedicines11030952","journal-title":"Biomedicines"},{"key":"10543_CR33","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1002\/ehf2.12155","volume":"4","author":"M Luedde","year":"2017","unstructured":"Luedde M, Winkler T, Heinsen F, R\u00fchlemann MC, Spehlmann ME, Bajrovic A, Lieb W, Franke A, Ott SJ, Frey N (2017) Heart failure is associated with depletion of core intestinal microbiota. ESC Heart Fail 4:282\u2013290. https:\/\/doi.org\/10.1002\/ehf2.12155","journal-title":"ESC Heart Fail"},{"key":"10543_CR34","doi-asserted-by":"publisher","unstructured":"Sanderson E, Glymour MM, Holmes MV, Kang H, Morrison J, Munaf\u00f2 MR, Palmer T, Schooling CM, Wallace C, Zhao Q, Smith GD (2022) Mendelian randomization. Nature Reviews Methods Primers 2. https:\/\/doi.org\/10.1038\/s43586-021-00092-5","DOI":"10.1038\/s43586-021-00092-5"},{"key":"10543_CR35","doi-asserted-by":"publisher","DOI":"10.1002\/ehf2.15267","author":"L Huang","year":"2025","unstructured":"Huang L, Zhao X, Wang J, Guan J, Huang B, Feng J, Li X, Zhang Y, Zhang J (2025) Gut microbiota and risk of heart failure in European population\u2014a comprehensive Mendelian randomization study. ESC Heart Failure. https:\/\/doi.org\/10.1002\/ehf2.15267","journal-title":"ESC Heart Failure"},{"key":"10543_CR36","doi-asserted-by":"publisher","unstructured":"Luo Q, Hu Y, Chen X, Luo Y, Chen J, Wang H (2022) Effects of gut microbiota and metabolites on heart failure and its risk factors: a two-sample Mendelian randomization study. Frontiers in Nutrition 9. https:\/\/doi.org\/10.3389\/fnut.2022.899746","DOI":"10.3389\/fnut.2022.899746"},{"key":"10543_CR37","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1093\/eurjpc\/zwad171","volume":"30","author":"H Dai","year":"2023","unstructured":"Dai H, Hou T, Wang Q, Hou Y, Wang T, Zheng J, Lin H, Zhao Z, Li M, Wang S, Zhang D, Dai M, Zheng R, Lu J, Xu Y, Chen Y, Ning G, Wang W, Bi Y, Xu M (2023) Causal relationships between the gut microbiome, blood lipids, and heart failure: a Mendelian randomization analysis. Eur J Prev Cardiol 30:1274\u20131282. https:\/\/doi.org\/10.1093\/eurjpc\/zwad171","journal-title":"Eur J Prev Cardiol"},{"key":"10543_CR38","doi-asserted-by":"publisher","first-page":"102235","DOI":"10.1016\/j.cpcardiol.2023.102235","volume":"49","author":"S Pang","year":"2023","unstructured":"Pang S, Han T, Huang X, Zhao Y, Qian J, Zhong J, Xie P, Liao L (2023) Exploring the potential causal relationship between gut microbiota and heart failure: a two-sample Mendelian randomization study combined with the geo database. Curr Probl Cardiol 49:102235. https:\/\/doi.org\/10.1016\/j.cpcardiol.2023.102235","journal-title":"Curr Probl Cardiol"},{"key":"10543_CR39","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1016\/j.jacc.2017.12.057","volume":"71","author":"M Kummen","year":"2018","unstructured":"Kummen M, Mayerhofer CCK, Vestad B, Broch K, Awoyemi A, Storm-Larsen C, Ueland T, Yndestad A, Hov JR, Tr\u00f8seid M (2018) Gut microbiota signature in heart failure defined from profiling of 2 independent cohorts. J Am Coll Cardiol 71:1184\u20131186. https:\/\/doi.org\/10.1016\/j.jacc.2017.12.057","journal-title":"J Am Coll Cardiol"},{"key":"10543_CR40","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.exger.2009.04.002","volume":"44","author":"J Zwielehner","year":"2009","unstructured":"Zwielehner J, Liszt K, Handschur M, Lassl C, Lapin A, Haslberger AG (2009) Combined PCR-DGGE fingerprinting and quantitative-PCR indicates shifts in fecal population sizes and diversity of Bacteroides, Bifidobacteria and Clostridium cluster IV in institutionalized elderly. Exp Gerontol 44:440\u2013446. https:\/\/doi.org\/10.1016\/j.exger.2009.04.002","journal-title":"Exp Gerontol"},{"key":"10543_CR41","doi-asserted-by":"publisher","first-page":"e0174099","DOI":"10.1371\/journal.pone.0174099","volume":"12","author":"T Kamo","year":"2017","unstructured":"Kamo T, Akazawa H, Suda W, Saga-Kamo A, Shimizu Y, Yagi H, Liu Q, Nomura S, Naito AT, Takeda N, Harada M, Toko H, Kumagai H, Ikeda Y, Takimoto E, Suzuki J, Honda K, Morita H, Hattori M, Komuro I (2017) Dysbiosis and compositional alterations with aging in the gut microbiota of patients with heart failure. PLoS ONE 12:e0174099. https:\/\/doi.org\/10.1371\/journal.pone.0174099","journal-title":"PLoS ONE"},{"key":"10543_CR42","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1016\/j.jacc.2014.06.1179","volume":"64","author":"A Sandek","year":"2014","unstructured":"Sandek A, Swidsinski A, Schroedl W, Watson A, Valentova M, Herrmann R, Scherbakov N, Cramer L, Rauchhaus M, Grosse-Herrenthey A, Krueger M, Von Haehling S, Doehner W, Anker SD, Bauditz J (2014) Intestinal blood flow in patients with chronic heart failure. J Am Coll Cardiol 64:1092\u20131102. https:\/\/doi.org\/10.1016\/j.jacc.2014.06.1179","journal-title":"J Am Coll Cardiol"},{"key":"10543_CR43","doi-asserted-by":"publisher","first-page":"813289","DOI":"10.3389\/fmicb.2021.813289","volume":"12","author":"W Sun","year":"2022","unstructured":"Sun W, Du D, Fu T, Han Y, Li P, Ju H (2022) Alterations of the gut microbiota in patients with severe chronic heart failure. Front Microbiol 12:813289. https:\/\/doi.org\/10.3389\/fmicb.2021.813289","journal-title":"Front Microbiol"},{"key":"10543_CR44","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1016\/j.healun.2020.02.004","volume":"39","author":"M Yuzefpolskaya","year":"2020","unstructured":"Yuzefpolskaya M, Bohn B, Nasiri M, Zuver AM, Onat DD, Royzman EA, Nwokocha J, Mabasa M, Pinsino A, Brunjes D, Gaudig A, Clemons A, Trinh P, Stump S, Giddins MJ, Topkara VK, Garan AR, Takeda K, Takayama H, Naka Y, Farr MA, Nandakumar R, Uhlemann A-C, Colombo PC, Demmer RT (2020) Gut microbiota, endotoxemia, inflammation, and oxidative stress in patients with heart failure, left ventricular assist device, and transplant. J Heart Lung Transplant 39:880\u2013890. https:\/\/doi.org\/10.1016\/j.healun.2020.02.004","journal-title":"J Heart Lung Transplant"},{"key":"10543_CR45","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1038\/s41598-017-18756-2","volume":"8","author":"X Cui","year":"2018","unstructured":"Cui X, Ye L, Li J, Jin L, Wang W, Li S, Bao M, Wu S, Li L, Geng B, Zhou X, Zhang J, Cai J (2018) Metagenomic and metabolomic analyses unveil dysbiosis of gut microbiota in chronic heart failure patients. Sci Rep 8:635. https:\/\/doi.org\/10.1038\/s41598-017-18756-2","journal-title":"Sci Rep"},{"key":"10543_CR46","doi-asserted-by":"publisher","first-page":"803744","DOI":"10.3389\/fcvm.2021.803744","volume":"8","author":"Z Huang","year":"2022","unstructured":"Huang Z, Mei X, Jiang Y, Chen T, Zhou Y (2022) Gut microbiota in heart failure patients with preserved ejection fraction (GUMPTION Study). Front Cardiovasc Med 8:803744. https:\/\/doi.org\/10.3389\/fcvm.2021.803744","journal-title":"Front Cardiovasc Med"},{"key":"10543_CR47","doi-asserted-by":"publisher","first-page":"1076806","DOI":"10.3389\/fcvm.2022.1076806","volume":"9","author":"Z Zhang","year":"2023","unstructured":"Zhang Z, Cai B, Sun Y, Deng H, Wang H, Qiao Z (2023) Alteration of the gut microbiota and metabolite phenylacetylglutamine in patients with severe chronic heart failure. Front Cardiovasc Med 9:1076806. https:\/\/doi.org\/10.3389\/fcvm.2022.1076806","journal-title":"Front Cardiovasc Med"},{"key":"10543_CR48","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.cmet.2013.03.013","volume":"17","author":"TQ de Aguiar Vallim","year":"2013","unstructured":"de Aguiar Vallim TQ, Tarling EJ, Edwards PA (2013) Pleiotropic roles of bile acids in metabolism. Cell Metab 17:657\u2013669. https:\/\/doi.org\/10.1016\/j.cmet.2013.03.013","journal-title":"Cell Metab"},{"key":"10543_CR49","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/j.cardfail.2017.06.007","volume":"23","author":"CCK Mayerhofer","year":"2017","unstructured":"Mayerhofer CCK, Ueland T, Broch K, Vincent RP, Cross GF, Dahl CP, Aukrust P, Gullestad L, Hov JR, Tr\u00f8seid M (2017) Increased secondary\/primary bile acid ratio in chronic heart failure. J Card Fail 23:666\u2013671. https:\/\/doi.org\/10.1016\/j.cardfail.2017.06.007","journal-title":"J Card Fail"},{"key":"10543_CR50","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1111\/j.1752-8062.2011.00272.x","volume":"4","author":"S Khurana","year":"2011","unstructured":"Khurana S, Raufman J, Pallone TL (2011) Bile acids regulate cardiovascular function. Clin Transl Sci 4:210\u2013218. https:\/\/doi.org\/10.1111\/j.1752-8062.2011.00272.x","journal-title":"Clin Transl Sci"},{"key":"10543_CR51","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/nrm3312","volume":"13","author":"AC Calkin","year":"2012","unstructured":"Calkin AC, Tontonoz P (2012) Transcriptional integration of metabolism by the nuclear sterol-activated receptors LXR and FXR. Nat Rev Mol Cell Biol 13:213\u2013224. https:\/\/doi.org\/10.1038\/nrm3312","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10543_CR52","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/S1097-2765(00)80348-2","volume":"3","author":"H Wang","year":"1999","unstructured":"Wang H, Chen J, Hollister K, Sowers LC, Forman BM (1999) Endogenous bile acids are ligands for the nuclear receptor FXR\/BAR. Mol Cell 3:543\u2013553. https:\/\/doi.org\/10.1016\/S1097-2765(00)80348-2","journal-title":"Mol Cell"},{"key":"10543_CR53","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1093\/eurheartj\/ehs011","volume":"34","author":"J Pu","year":"2013","unstructured":"Pu J, Yuan A, Shan P, Gao E, Wang X, Wang Y, Lau WB, Koch W, Ma X-L, He B (2013) Cardiomyocyte-expressed farnesoid-X-receptor is a novel apoptosis mediator and contributes to myocardial ischaemia\/reperfusion injury. Eur Heart J 34:1834\u20131845. https:\/\/doi.org\/10.1093\/eurheartj\/ehs011","journal-title":"Eur Heart J"},{"key":"10543_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000442479","volume":"9","author":"RB Radilla-V\u00e1zquez","year":"2016","unstructured":"Radilla-V\u00e1zquez RB, Parra-Rojas I, Mart\u00ednez-Hern\u00e1ndez NE, M\u00e1rquez-Sandoval YF, Illades-Aguiar B, Castro-Alarc\u00f3n N (2016) Gut microbiota and metabolic endotoxemia in young obese Mexican subjects. Obes Facts 9:1\u201311. https:\/\/doi.org\/10.1159\/000442479","journal-title":"Obes Facts"},{"key":"10543_CR55","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1128\/CMR.00008-07","volume":"20","author":"HM Wexler","year":"2007","unstructured":"Wexler HM (2007) Bacteroides\u202f: the good, the bad, and the nitty-gritty. Clin Microbiol Rev 20:593\u2013621. https:\/\/doi.org\/10.1128\/CMR.00008-07","journal-title":"Clin Microbiol Rev"},{"key":"10543_CR56","doi-asserted-by":"publisher","first-page":"3317","DOI":"10.1128\/IAI.01150-12","volume":"81","author":"PM Chilton","year":"2013","unstructured":"Chilton PM, Hadel DM, To TT, Mitchell TC, Darveau RP (2013) Adjuvant activity of naturally occurring monophosphoryl lipopolysaccharide preparations from mucosa-associated bacteria. Infect Immun 81:3317\u20133325. https:\/\/doi.org\/10.1128\/IAI.01150-12","journal-title":"Infect Immun"},{"key":"10543_CR57","first-page":"52","volume":"60","author":"M Majewska","year":"2006","unstructured":"Majewska M, Szczepanik M (2006) The role of Toll-like receptors (TLR) in innate and adaptive immune responses and their function in immune response regulation. Postepy Hig Med Doswiadczalnej Online 60:52\u201363","journal-title":"Postepy Hig Med Doswiadczalnej Online"},{"key":"10543_CR58","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/0167-5699(93)90212-4","volume":"14","author":"HWL Ziegler-Heitbrock","year":"1993","unstructured":"Ziegler-Heitbrock HWL, Ulevitch RJ (1993) CD14: Cell surface receptor and differentiation marker. Immunol Today 14:121\u2013125. https:\/\/doi.org\/10.1016\/0167-5699(93)90212-4","journal-title":"Immunol Today"},{"key":"10543_CR59","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1016\/j.cell.2020.02.041","volume":"180","author":"KA Fitzgerald","year":"2020","unstructured":"Fitzgerald KA, Kagan JC (2020) Toll-like receptors and the control of immunity. Cell 180:1044\u20131066. https:\/\/doi.org\/10.1016\/j.cell.2020.02.041","journal-title":"Cell"},{"key":"10543_CR60","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1177\/1753425918819754","volume":"25","author":"D Kiers","year":"2019","unstructured":"Kiers D, Leijte GP, Gerretsen J, Zwaag J, Kox M, Pickkers P (2019) Comparison of different lots of endotoxin and evaluation of in vivo potency over time in the experimental human endotoxemia model. Innate Immun 25:34\u201345. https:\/\/doi.org\/10.1177\/1753425918819754","journal-title":"Innate Immun"},{"key":"10543_CR61","doi-asserted-by":"publisher","first-page":"4999","DOI":"10.4049\/jimmunol.1402598","volume":"195","author":"S Guo","year":"2015","unstructured":"Guo S, Nighot M, Al-Sadi R, Alhmoud T, Nighot P, Ma TY (2015) Lipopolysaccharide regulation of intestinal tight junction permeability is mediated by TLR4 signal transduction pathway activation of FAK and MyD88. J Immunol 195:4999\u20135010. https:\/\/doi.org\/10.4049\/jimmunol.1402598","journal-title":"J Immunol"},{"key":"10543_CR62","doi-asserted-by":"publisher","first-page":"858","DOI":"10.3390\/nu3100858","volume":"3","author":"MAR Vinolo","year":"2011","unstructured":"Vinolo MAR, Rodrigues HG, Nachbar RT, Curi R (2011) Regulation of inflammation by short chain fatty acids. Nutrients 3:858\u2013876. https:\/\/doi.org\/10.3390\/nu3100858","journal-title":"Nutrients"},{"key":"10543_CR63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00394-017-1445-8","volume":"57","author":"I Rowland","year":"2018","unstructured":"Rowland I, Gibson G, Heinken A, Scott K, Swann J, Thiele I, Tuohy K (2018) Gut microbiota functions: metabolism of nutrients and other food components. Eur J Nutr 57:1\u201324. https:\/\/doi.org\/10.1007\/s00394-017-1445-8","journal-title":"Eur J Nutr"},{"key":"10543_CR64","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1079\/PNS2002207","volume":"62","author":"S Macfarlane","year":"2003","unstructured":"Macfarlane S, Macfarlane GT (2003) Regulation of short-chain fatty acid production. Proc Nutr Soc 62:67\u201372. https:\/\/doi.org\/10.1079\/PNS2002207","journal-title":"Proc Nutr Soc"},{"key":"10543_CR65","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1203\/01.pdr.0000250014.92242.f3","volume":"61","author":"L Peng","year":"2007","unstructured":"Peng L, He Z, Chen W, Holzman IR, Lin J (2007) Effects of butyrate on intestinal barrier function in a Caco-2 cell monolayer model of intestinal barrier. Pediatr Res 61:37\u201341. https:\/\/doi.org\/10.1203\/01.pdr.0000250014.92242.f3","journal-title":"Pediatr Res"},{"key":"10543_CR66","doi-asserted-by":"publisher","first-page":"842","DOI":"10.2214\/ajr.125.4.842","volume":"125","author":"YM Berkmen","year":"1975","unstructured":"Berkmen YM, Lande A (1975) Chest roentgenography as a window to the diagnosis of Takayasu\u2019s arteritis. Am J Roentgenol Radium Ther Nucl Med 125:842\u2013846. https:\/\/doi.org\/10.2214\/ajr.125.4.842","journal-title":"Am J Roentgenol Radium Ther Nucl Med"},{"key":"10543_CR67","doi-asserted-by":"publisher","first-page":"4457","DOI":"10.1038\/s41467-020-18262-6","volume":"11","author":"W Yang","year":"2020","unstructured":"Yang W, Yu T, Huang X, Bilotta AJ, Xu L, Lu Y, Sun J, Pan F, Zhou J, Zhang W, Yao S, Maynard CL, Singh N, Dann SM, Liu Z, Cong Y (2020) Intestinal microbiota-derived short-chain fatty acids regulation of immune cell IL-22 production and gut immunity. Nat Commun 11:4457. https:\/\/doi.org\/10.1038\/s41467-020-18262-6","journal-title":"Nat Commun"},{"key":"10543_CR68","doi-asserted-by":"publisher","first-page":"2826","DOI":"10.3748\/wjg.v13.i20.2826","volume":"13","author":"S Tedelind","year":"2007","unstructured":"Tedelind S, Westberg F, Kjerrulf M, Vidal A (2007) Anti-inflammatory properties of the short-chain fatty acids acetate and propionate: a study with relevance to inflammatory bowel disease. World J Gastroenterol 13:2826. https:\/\/doi.org\/10.3748\/wjg.v13.i20.2826","journal-title":"World J Gastroenterol"},{"key":"10543_CR69","doi-asserted-by":"publisher","first-page":"8272","DOI":"10.3390\/ijms23158272","volume":"23","author":"C Schiweck","year":"2022","unstructured":"Schiweck C, Edwin Thanarajah S, Aichholzer M, Matura S, Reif A, Vrieze E, Weigert A, Visekruna A (2022) Regulation of CD4+ and CD8+ T cell biology by short-chain fatty acids and its relevance for autoimmune pathology. Int J Mol Sci 23:8272. https:\/\/doi.org\/10.3390\/ijms23158272","journal-title":"Int J Mol Sci"},{"key":"10543_CR70","doi-asserted-by":"publisher","first-page":"4410","DOI":"10.1073\/pnas.1215927110","volume":"110","author":"JL Pluznick","year":"2013","unstructured":"Pluznick JL, Protzko RJ, Gevorgyan H, Peterlin Z, Sipos A, Han J, Brunet I, Wan L-X, Rey F, Wang T, Firestein SJ, Yanagisawa M, Gordon JI, Eichmann A, Peti-Peterdi J, Caplan MJ (2013) Olfactory receptor responding to gut microbiota-derived signals plays a role in renin secretion and blood pressure regulation. Proc Natl Acad Sci 110:4410\u20134415. https:\/\/doi.org\/10.1073\/pnas.1215927110","journal-title":"Proc Natl Acad Sci"},{"key":"10543_CR71","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1152\/physiolgenomics.00089.2016","volume":"48","author":"N Natarajan","year":"2016","unstructured":"Natarajan N, Hori D, Flavahan S, Steppan J, Flavahan NA, Berkowitz DE, Pluznick JL (2016) Microbial short chain fatty acid metabolites lower blood pressure via endothelial G protein-coupled receptor 41. Physiol Genomics 48:826\u2013834. https:\/\/doi.org\/10.1152\/physiolgenomics.00089.2016","journal-title":"Physiol Genomics"},{"key":"10543_CR72","doi-asserted-by":"publisher","first-page":"F439","DOI":"10.1152\/ajprenal.00252.2013","volume":"305","author":"JL Pluznick","year":"2013","unstructured":"Pluznick JL (2013) Renal and cardiovascular sensory receptors and blood pressure regulation. AJP Renal Physiology 305:F439\u2013F444. https:\/\/doi.org\/10.1152\/ajprenal.00252.2013","journal-title":"AJP Renal Physiology"},{"key":"10543_CR73","doi-asserted-by":"publisher","first-page":"H561","DOI":"10.1152\/ajpheart.1991.261.2.h561","volume":"261","author":"CW Nutting","year":"1991","unstructured":"Nutting CW, Islam S, Daugirdas JT (1991) Vasorelaxant effects of short chain fatty acid salts in rat caudal artery. AJP Heart and Circulatory Physiology 261:H561\u2013H567. https:\/\/doi.org\/10.1152\/ajpheart.1991.261.2.h561","journal-title":"AJP Heart and Circulatory Physiology"},{"key":"10543_CR74","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1136\/gut.31.12.1391","volume":"31","author":"FV Mortensen","year":"1990","unstructured":"Mortensen FV, Nielsen H, Mulvany MJ, Hessov I (1990) Short chain fatty acids dilate isolated human colonic resistance arteries. Gut 31:1391\u20131394. https:\/\/doi.org\/10.1136\/gut.31.12.1391","journal-title":"Gut"},{"key":"10543_CR75","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1161\/circulationaha.119.043081","volume":"141","author":"DM Kaye","year":"2020","unstructured":"Kaye DM, Shihata WA, Jama HA, Tsyganov K, Ziemann M, Kiriazis H, Horlock D, Vijay A, Giam B, Vinh A, Johnson C, Fiedler A, Donner D, Snelson M, Coughlan MT, Phillips S, Du X-J, El-Osta A, Drummond G, Lambert GW, Spector TD, Valdes AM, Mackay CR, Marques FZ (2020) Deficiency of prebiotic fiber and insufficient signaling through gut metabolite-sensing receptors leads to cardiovascular disease. Circulation 141:1393\u20131403. https:\/\/doi.org\/10.1161\/circulationaha.119.043081","journal-title":"Circulation"},{"key":"10543_CR76","doi-asserted-by":"publisher","unstructured":"Bennett BJ, Vallim TQ de A, Wang Z, Shih DM, Meng Y, Gregory J, Allayee H, Lee R, Graham M, Crooke R, Edwards PA, Hazen SL, Lusis AJ (2013) Trimethylamine-N-oxide, a metabolite associated with atherosclerosis, exhibits complex genetic and dietary regulation. Cell Metab 17:49\u201360. https:\/\/doi.org\/10.1016\/j.cmet.2012.12.011","DOI":"10.1016\/j.cmet.2012.12.011"},{"key":"10543_CR77","doi-asserted-by":"publisher","first-page":"1940","DOI":"10.3390\/ijms24031940","volume":"24","author":"M Canyelles","year":"2023","unstructured":"Canyelles M, Borr\u00e0s C, Rotllan N, Tondo M, Escol\u00e0-Gil JC, Blanco-Vaca F (2023) Gut microbiota-derived TMAO: a causal factor promoting atherosclerotic cardiovascular disease? Int J Mol Sci 24:1940. https:\/\/doi.org\/10.3390\/ijms24031940","journal-title":"Int J Mol Sci"},{"key":"10543_CR78","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/ehf2.12005","volume":"1","author":"P Ponikowski","year":"2014","unstructured":"Ponikowski P, Anker SD, AlHabib KF, Cowie MR, Force TL, Hu S, Jaarsma T, Krum H, Rastogi V, Rohde LE, Samal UC, Shimokawa H, Budi Siswanto B, Sliwa K, Filippatos G (2014) Heart failure: preventing disease and death worldwide. ESC Heart Fail 1:4\u201325. https:\/\/doi.org\/10.1002\/ehf2.12005","journal-title":"ESC Heart Fail"},{"key":"10543_CR79","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1002\/ehf2.12552","volume":"7","author":"X Zhou","year":"2020","unstructured":"Zhou X, Jin M, Liu L, Yu Z, Lu X, Zhang H (2020) Trimethylamine N-oxide and cardiovascular outcomes in patients with chronic heart failure after myocardial infarction. ESC Heart Fail 7:189\u2013194. https:\/\/doi.org\/10.1002\/ehf2.12552","journal-title":"ESC Heart Fail"},{"key":"10543_CR80","doi-asserted-by":"publisher","first-page":"3846","DOI":"10.1002\/ehf2.14009","volume":"9","author":"N Li","year":"2022","unstructured":"Li N, Zhou J, Wang Y, Chen R, Li J, Zhao X, Zhou P, Liu C, Song L, Liao Z, Wang X, Yan S, Zhao H, Yan H (2022) Association between trimethylamine N-oxide and prognosis of patients with acute myocardial infarction and heart failure. ESC Heart Fail 9:3846\u20133857. https:\/\/doi.org\/10.1002\/ehf2.14009","journal-title":"ESC Heart Fail"},{"key":"10543_CR81","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nature09922","volume":"472","author":"Z Wang","year":"2011","unstructured":"Wang Z, Klipfell E, Bennett BJ, Koeth R, Levison BS, DuGar B, Feldstein AE, Britt EB, Fu X, Chung Y-M, Wu Y, Schauer P, Smith JD, Allayee H, Tang WHW, DiDonato JA, Lusis AJ, Hazen SL (2011) Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature 472:57\u201363. https:\/\/doi.org\/10.1038\/nature09922","journal-title":"Nature"},{"key":"10543_CR82","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.toxlet.2016.12.017","volume":"267","author":"M Makrecka-Kuka","year":"2017","unstructured":"Makrecka-Kuka M, Volska K, Antone U, Vilskersts R, Grinberga S, Bandere D, Liepinsh E, Dambrova M (2017) Trimethylamine N-oxide impairs pyruvate and fatty acid oxidation in cardiac mitochondria. Toxicol Lett 267:32\u201338. https:\/\/doi.org\/10.1016\/j.toxlet.2016.12.017","journal-title":"Toxicol Lett"},{"key":"10543_CR83","doi-asserted-by":"publisher","first-page":"49982","DOI":"10.1074\/jbc.M209649200","volume":"277","author":"VV Kunjathoor","year":"2002","unstructured":"Kunjathoor VV, Febbraio M, Podrez EA, Moore KJ, Andersson L, Koehn S, Rhee JS, Silverstein R, Hoff HF, Freeman MW (2002) Scavenger receptors class A-I\/II and CD36 are the principal receptors responsible for the uptake of modified low density lipoprotein leading to lipid loading in macrophages. J Biol Chem 277:49982\u201349988. https:\/\/doi.org\/10.1074\/jbc.M209649200","journal-title":"J Biol Chem"},{"key":"10543_CR84","doi-asserted-by":"publisher","unstructured":"Ma G, Pan B, Chen Y, Guo C, Zhao M, Zheng L, Chen B (2017) Trimethylamine N-oxide in atherogenesis: impairing endothelial self-repair capacity and enhancing monocyte adhesion. Biosci Rep 37:BSR20160244. https:\/\/doi.org\/10.1042\/BSR20160244","DOI":"10.1042\/BSR20160244"},{"key":"10543_CR85","doi-asserted-by":"publisher","first-page":"e002767","DOI":"10.1161\/JAHA.115.002767","volume":"5","author":"MM Seldin","year":"2016","unstructured":"Seldin MM, Meng Y, Qi H, Zhu W, Wang Z, Hazen SL, Lusis AJ, Shih DM (2016) Trimethylamine N-oxide promotes vascular inflammation through signaling of mitogen-activated protein kinase and nuclear factor-\u03baB. J Am Heart Assoc 5:e002767. https:\/\/doi.org\/10.1161\/JAHA.115.002767","journal-title":"J Am Heart Assoc"},{"key":"10543_CR86","doi-asserted-by":"publisher","first-page":"944","DOI":"10.3389\/fphys.2017.00944","volume":"8","author":"H Zhang","year":"2017","unstructured":"Zhang H, Meng J, Yu H (2017) Trimethylamine N-oxide supplementation abolishes the cardioprotective effects of voluntary exercise in mice fed a western diet. Front Physiol 8:944. https:\/\/doi.org\/10.3389\/fphys.2017.00944","journal-title":"Front Physiol"},{"key":"10543_CR87","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1161\/CIRCRESAHA.119.315069","volume":"125","author":"B Chen","year":"2019","unstructured":"Chen B, Huang S, Su Y, Wu Y-J, Hanna A, Brickshawana A, Graff J, Frangogiannis NG (2019) Macrophage Smad3 protects the infarcted heart, stimulating phagocytosis and regulating inflammation. Circ Res 125:55\u201370. https:\/\/doi.org\/10.1161\/CIRCRESAHA.119.315069","journal-title":"Circ Res"},{"key":"10543_CR88","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/s41374-018-0091-y","volume":"99","author":"Z Li","year":"2019","unstructured":"Li Z, Wu Z, Yan J, Liu H, Liu Q, Deng Y, Ou C, Chen M (2019) Gut microbe-derived metabolite trimethylamine N-oxide induces cardiac hypertrophy and fibrosis. Lab Invest 99:346\u2013357. https:\/\/doi.org\/10.1038\/s41374-018-0091-y","journal-title":"Lab Invest"},{"key":"10543_CR89","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1161\/CIRCGEN.119.002314","volume":"12","author":"S Tuteja","year":"2019","unstructured":"Tuteja S, Ferguson JF (2019) Gut microbiome and response to cardiovascular drugs. Circ Genomic Precis Med 12:421\u2013429. https:\/\/doi.org\/10.1161\/CIRCGEN.119.002314","journal-title":"Circ Genomic Precis Med"},{"key":"10543_CR90","doi-asserted-by":"publisher","unstructured":"Zhernakova A, Kurilshikov A, Bonder MJ, Tigchelaar EF, Schirmer M, Vatanen T, Mujagic Z, Vila AV, Falony G, Vieira-Silva S, Wang J, Imhann F, Brandsma E, Jankipersadsing SA, Joossens M, Cenit MC, Deelen P, Swertz MA, LifeLines cohort study, Weersma RK, Feskens EJM, Netea MG, Gevers D, Jonkers D, Franke L, Aulchenko YS, Huttenhower C, Raes J, Hofker MH, Xavier RJ, Wijmenga C, Fu J (2016) Population-based metagenomics analysis reveals markers for gut microbiome composition and diversity. Science 352:565\u2013569. https:\/\/doi.org\/10.1126\/science.aad3369","DOI":"10.1126\/science.aad3369"},{"key":"10543_CR91","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1161\/ATVBAHA.123.319458","volume":"44","author":"K Koponen","year":"2024","unstructured":"Koponen K, Kambur O, Joseph B, Ruuskanen MO, Jousilahti P, Salido R, Brennan C, Jain M, Meric G, Inouye M, Lahti L, Niiranen T, Havulinna AS, Knight R, Salomaa V (2024) Role of gut microbiota in statin-associated new-onset diabetes\u2014a cross-sectional and prospective analysis of the FINRISK 2002 cohort. Arterioscler Thromb Vasc Biol 44:477\u2013487. https:\/\/doi.org\/10.1161\/ATVBAHA.123.319458","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10543_CR92","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1089\/omi.2017.0130","volume":"22","author":"TJ Khan","year":"2018","unstructured":"Khan TJ, Ahmed YM, Zamzami MA, Siddiqui AM, Khan I, Baothman OAS, Mehanna MG, Kuerban A, Kaleemuddin M, Yasir M (2018) Atorvastatin treatment modulates the gut microbiota of the hypercholesterolemic patients. OMICS J Integr Biol 22:154\u2013163. https:\/\/doi.org\/10.1089\/omi.2017.0130","journal-title":"OMICS J Integr Biol"},{"key":"10543_CR93","doi-asserted-by":"publisher","first-page":"530","DOI":"10.3389\/fmicb.2018.00530","volume":"9","author":"Y Liu","year":"2018","unstructured":"Liu Y, Song X, Zhou H, Zhou X, Xia Y, Dong X, Zhong W, Tang S, Wang L, Wen S, Xiao J, Tang L (2018) Gut microbiome associates with lipid-lowering effect of rosuvastatin in vivo. Front Microbiol 9:530. https:\/\/doi.org\/10.3389\/fmicb.2018.00530","journal-title":"Front Microbiol"},{"key":"10543_CR94","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1017\/S0007114511004703","volume":"107","author":"ML Jones","year":"2012","unstructured":"Jones ML, Martoni CJ, Parent M, Prakash S (2012) Cholesterol-lowering efficacy of a microencapsulated bile salt hydrolase-active Lactobacillus reuteri NCIMB 30242 yoghurt formulation in hypercholesterolaemic adults. Br J Nutr 107:1505\u20131513. https:\/\/doi.org\/10.1017\/S0007114511004703","journal-title":"Br J Nutr"},{"key":"10543_CR95","doi-asserted-by":"publisher","first-page":"104177","DOI":"10.1016\/j.jff.2020.104177","volume":"74","author":"J Jiang","year":"2020","unstructured":"Jiang J, Wu C, Zhang C, Zhao J, Yu L, Zhang H, Narbad A, Chen W, Zhai Q (2020) Effects of probiotic supplementation on cardiovascular risk factors in hypercholesterolemia: a systematic review and meta-analysis of randomized clinical trial. J Funct Foods 74:104177. https:\/\/doi.org\/10.1016\/j.jff.2020.104177","journal-title":"J Funct Foods"},{"key":"10543_CR96","doi-asserted-by":"publisher","DOI":"10.1002\/ehf2.15105","author":"M Volterrani","year":"2024","unstructured":"Volterrani M, Seferovic P, Savarese G, Spoletini I, Imbalzano E, Bayes-Genis A, Jankowska E, Senni M, Metra M, Chioncel O, Coats AJS, Rosano GMC (2024) Implementation of guideline-recommended medical therapy for patients with heart failure in Europe. ESC Heart Failure. https:\/\/doi.org\/10.1002\/ehf2.15105","journal-title":"ESC Heart Failure"},{"key":"10543_CR97","doi-asserted-by":"publisher","first-page":"861829","DOI":"10.3389\/fcell.2022.861829","volume":"10","author":"Y Dong","year":"2022","unstructured":"Dong Y, Wang P, Jiao J, Yang X, Chen M, Li J (2022) Antihypertensive therapy by ACEI\/ARB is associated with intestinal flora alterations and metabolomic profiles in hypertensive patients. Front Cell Dev Biol 10:861829. https:\/\/doi.org\/10.3389\/fcell.2022.861829","journal-title":"Front Cell Dev Biol"},{"key":"10543_CR98","doi-asserted-by":"publisher","first-page":"177183","DOI":"10.1016\/j.ejphar.2024.177183","volume":"987","author":"A Sharma","year":"2025","unstructured":"Sharma A, Kapur S, Kancharla P, Yang T (2025) Sex differences in gut microbiota, hypertension, and cardiovascular risk. Eur J Pharmacol 987:177183. https:\/\/doi.org\/10.1016\/j.ejphar.2024.177183","journal-title":"Eur J Pharmacol"},{"key":"10543_CR99","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1097\/HJH.0000000000000773","volume":"34","author":"HH Yoo","year":"2016","unstructured":"Yoo HH, Kim IS, Yoo D-H, Kim D-H (2016) Effects of orally administered antibiotics on the bioavailability of amlodipine: gut microbiota-mediated drug interaction. J Hypertens 34:156\u2013162. https:\/\/doi.org\/10.1097\/HJH.0000000000000773","journal-title":"J Hypertens"},{"key":"10543_CR100","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1002\/ehf2.14646","volume":"11","author":"H Liu","year":"2024","unstructured":"Liu H, Su Y, Shen J, Jiao Y, Li Y, Liu B, Hou X, Jin Q, Chen Y, Sun Z, Xi Q, Feng B, Fu Z (2024) Improved heart function and cardiac remodelling following sacubitril\/valsartan in acute coronary syndrome with HF. ESC Heart Failure 11:937\u2013949. https:\/\/doi.org\/10.1002\/ehf2.14646","journal-title":"ESC Heart Failure"},{"key":"10543_CR101","doi-asserted-by":"publisher","unstructured":"Wang P, Guo R, Bai X, Cui W, Zhang Y, Li H, Shang J, Zhao Z (2022) Sacubitril\/Valsartan contributes to improving the diabetic kidney disease and regulating the gut microbiota in mice. Frontiers in Endocrinology 13. https:\/\/doi.org\/10.3389\/fendo.2022.1034818","DOI":"10.3389\/fendo.2022.1034818"},{"key":"10543_CR102","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1007\/s11325-023-02781-9","volume":"27","author":"J Wang","year":"2023","unstructured":"Wang J, Zhang H, Wu L, Lu D (2023) Sacubitril\/valsartan mitigated intermittent hypoxia related intestinal microbiota alteration and aortic injury. Sleep and Breathing 27:1769\u20131777. https:\/\/doi.org\/10.1007\/s11325-023-02781-9","journal-title":"Sleep and Breathing"},{"key":"10543_CR103","doi-asserted-by":"publisher","unstructured":"Colombo G, Biering\u2010Sorensen T, Ferreira JP, Lombardi CM, Bonelli A, Garascia A, Metra M, Inciardi RM (2024) Cardiac remodelling in the era of the recommended four pillars heart failure medical therapy. ESC Heart Fail ehf2.15095. https:\/\/doi.org\/10.1002\/ehf2.15095","DOI":"10.1002\/ehf2.15095"},{"key":"10543_CR104","doi-asserted-by":"publisher","first-page":"114149","DOI":"10.1016\/j.biopha.2022.114149","volume":"158","author":"C Gonz\u00e1lez-Correa","year":"2023","unstructured":"Gonz\u00e1lez-Correa C, Mole\u00f3n J, Mi\u00f1ano S, Robles-Vera I, Toral M, Mart\u00edn-Morales N, O\u2019Valle F, S\u00e1nchez M, G\u00f3mez-Guzm\u00e1n M, Jim\u00e9nez R, Romero M, Duarte J (2023) Mineralocorticoid receptor blockade improved gut microbiota dysbiosis by reducing gut sympathetic tone in spontaneously hypertensive rats. Biomed Pharmacother 158:114149. https:\/\/doi.org\/10.1016\/j.biopha.2022.114149","journal-title":"Biomed Pharmacother"},{"key":"10543_CR105","doi-asserted-by":"publisher","first-page":"e15589","DOI":"10.7717\/peerj.15589","volume":"11","author":"N Bao","year":"2023","unstructured":"Bao N, Liu X, Zhong X, Jia S, Hua N, Zhang L, Mo G (2023) Dapagliflozin-affected endothelial dysfunction and altered gut microbiota in mice with heart failure. PeerJ 11:e15589. https:\/\/doi.org\/10.7717\/peerj.15589","journal-title":"PeerJ"},{"key":"10543_CR106","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s10157-022-02312-y","volume":"27","author":"A Matsui","year":"2023","unstructured":"Matsui A, Yoshifuji A, Irie J, Tajima T, Uchiyama K, Itoh T, Wakino S, Itoh H (2023) Canagliflozin protects the cardiovascular system through effects on the gut environment in non-diabetic nephrectomized rats. Clin Exp Nephrol 27:295\u2013308. https:\/\/doi.org\/10.1007\/s10157-022-02312-y","journal-title":"Clin Exp Nephrol"},{"key":"10543_CR107","doi-asserted-by":"publisher","first-page":"175172","DOI":"10.1016\/j.ejphar.2022.175172","volume":"931","author":"EM Khalaf","year":"2022","unstructured":"Khalaf EM, Hassan HM, El-Baz AM, Shata A, Khodir AE, Yousef ME, Elgharabawy RM, Nouh NA, Saleh S, Bin-Meferij MM, El-kott AF, El-Sokkary MMA, Eissa H (2022) A novel therapeutic combination of dapagliflozin, Lactobacillus and crocin attenuates diabetic cardiomyopathy in rats: role of oxidative stress, gut microbiota, and PPAR\u03b3 activation. Eur J Pharmacol 931:175172. https:\/\/doi.org\/10.1016\/j.ejphar.2022.175172","journal-title":"Eur J Pharmacol"},{"key":"10543_CR108","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.2147\/DDDT.S404479","volume":"17","author":"X-Q Guan","year":"2023","unstructured":"Guan X-Q, Wang C-H, Cheng P, Fu L-Y, Wu Q-J, Cheng G, Guan L, Sun Z-J (2023) Effects of empagliflozin on gut microbiota in heart failure with a preserved ejection fraction: the design of a pragmatic randomized, open-label controlled trial (EMPAGUM). Drug Des Devel Ther 17:1495\u20131502. https:\/\/doi.org\/10.2147\/DDDT.S404479","journal-title":"Drug Des Devel Ther"},{"key":"10543_CR109","doi-asserted-by":"publisher","unstructured":"Rahman MdM, Islam F, -Or-Rashid MdH, Mamun AA, Rahaman MdS, Islam MdM, Meem AFK, Sutradhar PR, Mitra S, Mimi AA, Emran TB, Fatimawali, Idroes R, Tallei TE, Ahmed M, Cavalu S (2022) The gut microbiota (microbiome) in cardiovascular disease and its therapeutic regulation. Front Cell Infect Microbiol 12:903570. https:\/\/doi.org\/10.3389\/fcimb.2022.903570","DOI":"10.3389\/fcimb.2022.903570"},{"key":"10543_CR110","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1016\/j.ejcts.2008.02.014","volume":"33","author":"YS Tjang","year":"2008","unstructured":"Tjang YS, Van Der Heijden GJMG, Tenderich G, Grobbee DE, K\u00f6rfer R (2008) Survival analysis in heart transplantation: results from an analysis of 1290 cases in a single center. Eur J Cardiothorac Surg 33:856\u2013861. https:\/\/doi.org\/10.1016\/j.ejcts.2008.02.014","journal-title":"Eur J Cardiothorac Surg"},{"key":"10543_CR111","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1086\/322733","volume":"33","author":"JG Montoya","year":"2001","unstructured":"Montoya JG, Giraldo LF, Efron B, Stinson EB, Gamberg P, Hunt S, Giannetti N, Miller J, Remington JS (2001) Infectious complications among 620 consecutive heart transplant patients at Stanford University Medical Center. Clin Infect Dis 33:629\u2013640. https:\/\/doi.org\/10.1086\/322733","journal-title":"Clin Infect Dis"},{"key":"10543_CR112","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/nature25979","volume":"555","author":"L Maier","year":"2018","unstructured":"Maier L, Pruteanu M, Kuhn M, Zeller G, Telzerow A, Anderson EE, Brochado AR, Fernandez KC, Dose H, Mori H, Patil KR, Bork P, Typas A (2018) Extensive impact of non-antibiotic drugs on human gut bacteria. Nature 555:623\u2013628. https:\/\/doi.org\/10.1038\/nature25979","journal-title":"Nature"},{"key":"10543_CR113","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.healun.2022.10.015","volume":"42","author":"A Velleca","year":"2023","unstructured":"Velleca A, Shullo MA, Dhital K, Azeka E, Colvin M, DePasquale E, Farrero M, Garc\u00eda-Guereta L, Jamero G, Khush K, Lavee J, Pouch S, Patel J, Michaud C, Shullo MA, Schubert S, Angelini A, Carlos L, Mirabet S, Patel J, Pham M, Urschel S, Kim K-H, Miyamoto S, Chih S, Daly K, Grossi P, Jennings DL, Kim I, Lim HS, Miller T, Potena L, Velleca A, Eisen H, Bellumkonda L, Danziger-Isakov L, Dobbels F, Harkess M, Kim D, Lyster H, Peled Y, Reinhardt Z (2023) The International Society for Heart and Lung Transplantation (ISHLT) guidelines for the care of heart transplant recipients. J Heart Lung Transplant 42:e1\u2013e141. https:\/\/doi.org\/10.1016\/j.healun.2022.10.015","journal-title":"J Heart Lung Transplant"},{"key":"10543_CR114","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1097\/FTD.0000000000000125","volume":"37","author":"S Lin","year":"2015","unstructured":"Lin S, Henning AK, Akhlaghi F, Reisfield R, Vergara-Silva A, First MR (2015) Interleukin-2 receptor antagonist therapy leads to increased tacrolimus levels after kidney transplantation. Ther Drug Monit 37:206\u2013213. https:\/\/doi.org\/10.1097\/FTD.0000000000000125","journal-title":"Ther Drug Monit"},{"key":"10543_CR115","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1111\/ajt.14661","volume":"18","author":"Z Zhang","year":"2018","unstructured":"Zhang Z, Liu L, Tang H, Jiao W, Zeng S, Xu Y, Zhang Q, Sun Z, Mukherjee A, Zhang X, Hu X (2018) Immunosuppressive effect of the gut microbiome altered by high-dose tacrolimus in mice. Am J Transplant 18:1646\u20131656. https:\/\/doi.org\/10.1111\/ajt.14661","journal-title":"Am J Transplant"},{"key":"10543_CR116","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/S0162-3109(00)00192-2","volume":"47","author":"S Matsuda","year":"2000","unstructured":"Matsuda S, Koyasu S (2000) Mechanisms of action of cyclosporine. Immunopharmacology 47:119\u2013125. https:\/\/doi.org\/10.1016\/S0162-3109(00)00192-2","journal-title":"Immunopharmacology"},{"key":"10543_CR117","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1099\/jmm.0.001130","volume":"69","author":"C O\u2019Reilly","year":"2020","unstructured":"O\u2019Reilly C, O\u2019Sullivan \u00d3, Cotter PD, O\u2019Connor PM, Shanahan F, Cullen A, Rea MC, Hill C, Coulter I, Ross RP (2020) Encapsulated cyclosporine does not change the composition of the human microbiota when assessed ex vivo and in vivo. J Med Microbiol 69:854\u2013863. https:\/\/doi.org\/10.1099\/jmm.0.001130","journal-title":"J Med Microbiol"},{"key":"10543_CR118","doi-asserted-by":"publisher","first-page":"1342354","DOI":"10.3389\/fcimb.2024.1342354","volume":"14","author":"M Jardou","year":"2024","unstructured":"Jardou M, Brossier C, Marquet P, Picard N, Druilhe A, Lawson R (2024) Solid organ transplantation and gut microbiota: a review of the potential immunomodulatory properties of short-chain fatty acids in graft maintenance. Front Cell Infect Microbiol 14:1342354. https:\/\/doi.org\/10.3389\/fcimb.2024.1342354","journal-title":"Front Cell Infect Microbiol"},{"key":"10543_CR119","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1097\/MOT.0000000000000921","volume":"26","author":"JS Kim","year":"2021","unstructured":"Kim JS, Sze C, Barbar T, Lee JR (2021) New insights into the microbiome in kidney transplantation. Curr Opin Organ Transplant 26:582\u2013586. https:\/\/doi.org\/10.1097\/MOT.0000000000000921","journal-title":"Curr Opin Organ Transplant"},{"key":"10543_CR120","doi-asserted-by":"publisher","first-page":"e0233646","DOI":"10.1371\/journal.pone.0233646","volume":"15","author":"DL Jennings","year":"2020","unstructured":"Jennings DL, Bohn B, Zuver A, Onat D, Gaine M, Royzman E, Hupf J, Brunjes D, Latif F, Restaino S, Garan AR, Topkara VK, Takayama H, Takeda K, Naka Y, Farr M, Nandakumar R, Uhlemann A-C, Colombo PC, Demmer RT, Yuzefpolskaya M (2020) Gut microbial diversity, inflammation, and oxidative stress are associated with tacrolimus dosing requirements early after heart transplantation. PLoS ONE 15:e0233646. https:\/\/doi.org\/10.1371\/journal.pone.0233646","journal-title":"PLoS ONE"},{"key":"10543_CR121","doi-asserted-by":"publisher","first-page":"294","DOI":"10.3390\/biomedicines11020294","volume":"11","author":"C Campbell","year":"2023","unstructured":"Campbell C, Kandalgaonkar MR, Golonka RM, Yeoh BS, Vijay-Kumar M, Saha P (2023) Crosstalk between gut microbiota and host immunity: impact on inflammation and immunotherapy. Biomedicines 11:294. https:\/\/doi.org\/10.3390\/biomedicines11020294","journal-title":"Biomedicines"},{"key":"10543_CR122","doi-asserted-by":"publisher","unstructured":"Organ CL, Otsuka H, Bhushan S, Wang Z, Bradley J, Trivedi R, Polhemus DJ, Tang WHW, Wu Y, Hazen SL, Lefer DJ (2016) Choline diet and its gut microbe\u2013derived metabolite, trimethylamine N-oxide, exacerbate pressure overload\u2013induced heart failure. Circ Heart Fail 9:. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.115.002314","DOI":"10.1161\/CIRCHEARTFAILURE.115.002314"},{"key":"10543_CR123","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1016\/j.healun.2019.06.003","volume":"38","author":"M Tr\u00f8seid","year":"2019","unstructured":"Tr\u00f8seid M, Mayerhofer CCK, Broch K, Arora S, Svardal A, Hov JR, Andreassen AK, Gude E, Karason K, Dellgren G, Berge RK, Gullestad L, Aukrust P, Ueland T (2019) The carnitine-butyrobetaine-TMAO pathway after cardiac transplant: impact on cardiac allograft vasculopathy and acute rejection. J Heart Lung Transplant 38:1097\u20131103. https:\/\/doi.org\/10.1016\/j.healun.2019.06.003","journal-title":"J Heart Lung Transplant"}],"container-title":["Heart Failure Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-025-10543-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10741-025-10543-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-025-10543-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T20:03:26Z","timestamp":1763150606000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10741-025-10543-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,9]]},"references-count":123,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["10543"],"URL":"https:\/\/doi.org\/10.1007\/s10741-025-10543-w","relation":{},"ISSN":["1573-7322"],"issn-type":[{"value":"1573-7322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,9]]},"assertion":[{"value":"20 June 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The manuscript does not contain clinical studies or patient data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}